IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
Acute Lymphoblastic Leukemia (ALL) is the most common neoplasm in pediatric age. In recent years, between 15 and 20% of patients failed in their treatments. Knowledge on cytogenetics and molecular biology has an important impact on the determination of the prognosis and the appropriate treatment sch...
Main Authors: | Y.C. Castro, R. Utrera |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedad Argentina de Genética
2020-07-01
|
Series: | BAG. Journal of Basic and Applied Genetics |
Subjects: | |
Online Access: | https://sag.org.ar/jbag/wp-content/uploads/2020/07/v31n1a04.pdf |
Similar Items
-
Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
by: Patrycja Leszczenko, et al.
Published: (2021-10-01) -
Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia
by: Didier Ismael May-Hau, et al.
Published: (2022-06-01) -
The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1‐positive acute lymphoblastic leukemia
by: Congcong Sun, et al.
Published: (2019-10-01) -
CDK6 Inhibition: A Novel Approach in AML Management
by: Iris Z. Uras, et al.
Published: (2020-04-01) -
Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction
by: Jan Kulis, et al.
Published: (2022-07-01)